{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:03:24Z","timestamp":1792569804035,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A large fraction of the adult population is on lifelong medication for cardiovascular disorders, but the metabolic consequences are largely unknown. This study determines the effects of common anti-hypertensive and lipid lowering drugs on circulating plasma protein biomarkers. We studied 425 proteins in plasma together with anthropometric and lifestyle variables, and the genetic profile in a cross-sectional cohort. We found 8406 covariate-protein associations, and a two-stage GWAS identified 17253 SNPs to be associated with 109 proteins. By computationally removing variation due to lifestyle and genetic factors, we could determine that medication, per se, affected the abundance levels of 35.7% of the plasma proteins. Medication either affected a single, a few, or a large number of protein, and were found to have a negative or positive influence on known disease pathways and biomarkers. Anti-hypertensive or lipid lowering drugs affected 33.1% of the proteins. Angiotensin-converting enzyme inhibitors showed the strongest lowering effect by decreasing plasma levels of myostatin. Cell-culture experiments showed that angiotensin-converting enzyme inhibitors reducted myostatin RNA levels. Thus, understanding the effects of lifelong medication on the plasma proteome is important both for sharpening the diagnostic precision of protein biomarkers and in disease management.<\/jats:p>","DOI":"10.1038\/s41598-018-23860-y","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T02:26:28Z","timestamp":1522290388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5056-9137","authenticated-orcid":false,"given":"Stefan","family":"Enroth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-0839","authenticated-orcid":false,"given":"Varun","family":"Maturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Berggrund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Bosdotter","family":"Enroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis","family":"Moustakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2915-4498","authenticated-orcid":false,"given":"\u00c5sa","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Gyllensten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"23860_CR1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.jacc.2015.02.038","volume":"65","author":"C Rosendorff","year":"2015","unstructured":"Rosendorff, C. et al. Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Journal of the American College of Cardiology 65, 1998\u20132038, https:\/\/doi.org\/10.1016\/j.jacc.2015.02.038 (2015).","journal-title":"Journal of the American College of Cardiology"},{"key":"23860_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","volume":"386","author":"NR Poulter","year":"2015","unstructured":"Poulter, N. R., Prabhakaran, D. & Caulfield, M. Hypertension. Lancet 386, 801\u2013812, https:\/\/doi.org\/10.1016\/S0140-6736(14)61468-9 (2015).","journal-title":"Lancet"},{"key":"23860_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/bmj.326.7391.681","volume":"326","author":"K Dunder","year":"2003","unstructured":"Dunder, K., Lind, L., Zethelius, B., Berglund, L. & Lithell, H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ 326, 681, https:\/\/doi.org\/10.1136\/bmj.326.7391.681 (2003).","journal-title":"BMJ"},{"key":"23860_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","volume":"274","author":"BM Psaty","year":"1995","unstructured":"Psaty, B. M. et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA: the journal of the American Medical Association 274, 620\u2013625 (1995).","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"23860_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.3675","volume":"23","author":"FM Brouwers","year":"2014","unstructured":"Brouwers, F. M. et al. Beta-blockers are associated with increased risk of first cardiovascular events in non-diabetic hypertensive elderly patients. Pharmacoepidemiol Drug Saf 23, 1139\u20131146, https:\/\/doi.org\/10.1002\/pds.3675 (2014).","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"23860_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5684","volume":"5","author":"S Enroth","year":"2014","unstructured":"Enroth, S., Johansson, A., Enroth, S. B. & Gyllensten, U. Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs. Nat Commun 5, 4684, https:\/\/doi.org\/10.1038\/ncomms5684 (2014).","journal-title":"Nat Commun"},{"key":"23860_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/1354750X.2015.1093546","volume":"20","author":"S Enroth","year":"2015","unstructured":"Enroth, S., Bosdotter Enroth, S., Johansson, A. & Gyllensten, U. Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP). Biomarkers 20, 355\u2013364, https:\/\/doi.org\/10.3109\/1354750X.2015.1093546 (2015).","journal-title":"Biomarkers"},{"key":"23860_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cyto.2015.07.010","volume":"76","author":"A Larsson","year":"2015","unstructured":"Larsson, A. et al. The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid. Cytokine 76, 514\u2013518, https:\/\/doi.org\/10.1016\/j.cyto.2015.07.010 (2015).","journal-title":"Cytokine"},{"key":"23860_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jim.2015.06.009","volume":"425","author":"A Larsson","year":"2015","unstructured":"Larsson, A. et al. The effects of age and gender on plasma levels of 63 cytokines. J Immunol Methods 425, 58\u201361, https:\/\/doi.org\/10.1016\/j.jim.2015.06.009 (2015).","journal-title":"J Immunol Methods"},{"key":"23860_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1074\/mcp.M600160-MCP200","volume":"6","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics 6, 64\u201371, https:\/\/doi.org\/10.1074\/mcp.M600160-MCP200 (2007).","journal-title":"Mol Cell Proteomics"},{"key":"23860_CR11","doi-asserted-by":"publisher","first-page":"D959","DOI":"10.1093\/nar\/gkt1251","volume":"42","author":"V Nanjappa","year":"2014","unstructured":"Nanjappa, V. et al. Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res 42, D959\u2013965, https:\/\/doi.org\/10.1093\/nar\/gkt1251 (2014).","journal-title":"Nucleic Acids Res"},{"key":"23860_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","volume":"2","author":"PE Geyer","year":"2016","unstructured":"Geyer, P. E. et al. Plasma Proteome Profiling to Assess Human Health and Disease. Cell Syst 2, 185\u2013195, https:\/\/doi.org\/10.1016\/j.cels.2016.02.015 (2016).","journal-title":"Cell Syst"},{"key":"23860_CR13","doi-asserted-by":"publisher","first-page":"e0156914","DOI":"10.1371\/journal.pone.0156914","volume":"11","author":"S McLachlan","year":"2016","unstructured":"McLachlan, S. et al. Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans. PLoS One 11, e0156914, https:\/\/doi.org\/10.1371\/journal.pone.0156914 (2016).","journal-title":"PLoS One"},{"key":"23860_CR14","doi-asserted-by":"publisher","first-page":"D171","DOI":"10.1093\/nar\/gks1221","volume":"41","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. Factorbook.org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic Acids Res 41, D171\u2013176, https:\/\/doi.org\/10.1093\/nar\/gks1221 (2013).","journal-title":"Nucleic Acids Res"},{"key":"23860_CR15","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1101\/gr.139105.112","volume":"22","author":"J Wang","year":"2012","unstructured":"Wang, J. et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res 22, 1798\u20131812, https:\/\/doi.org\/10.1101\/gr.139105.112 (2012).","journal-title":"Genome Res"},{"key":"23860_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature11245","volume":"489","author":"MB Gerstein","year":"2012","unstructured":"Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91\u2013100, https:\/\/doi.org\/10.1038\/nature11245 (2012).","journal-title":"Nature"},{"key":"23860_CR17","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","volume":"71","author":"M Fujita","year":"2011","unstructured":"Fujita, M. et al. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 71, 2664\u20132674, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3055 (2011).","journal-title":"Cancer Res"},{"key":"23860_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12265-016-9703-3","volume":"9","author":"R Altara","year":"2016","unstructured":"Altara, R. et al. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study. J Cardiovasc Transl Res 9, 302\u2013314, https:\/\/doi.org\/10.1007\/s12265-016-9703-3 (2016).","journal-title":"J Cardiovasc Transl Res"},{"key":"23860_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Cholesterol Treatment Trialists","year":"2010","unstructured":"Cholesterol Treatment Trialists, C. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376, 1670\u20131681, https:\/\/doi.org\/10.1016\/S0140-6736(10)61350-5 (2010).","journal-title":"Lancet"},{"key":"23860_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington, W., Lacey, B., Sherliker, P., Armitage, J. & Lewington, S. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res 118, 535\u2013546, https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307611 (2016).","journal-title":"Circ Res"},{"key":"23860_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.269","volume":"41","author":"YS Aulchenko","year":"2009","unstructured":"Aulchenko, Y. S. et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nature genetics 41, 47\u201355, https:\/\/doi.org\/10.1038\/ng.269 (2009).","journal-title":"Nature genetics"},{"key":"23860_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/039463201202500208","volume":"25","author":"A Antonelli","year":"2012","unstructured":"Antonelli, A. et al. High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension. International journal of immunopathology and pharmacology 25, 387\u2013395 (2012).","journal-title":"International journal of immunopathology and pharmacology"},{"key":"23860_CR23","doi-asserted-by":"publisher","first-page":"40735","DOI":"10.1074\/jbc.M206379200","volume":"277","author":"JJ Hill","year":"2002","unstructured":"Hill, J. J. et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277, 40735\u201340741, https:\/\/doi.org\/10.1074\/jbc.M206379200 (2002).","journal-title":"J Biol Chem"},{"key":"23860_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ydbio.2004.01.046","volume":"270","author":"H Amthor","year":"2004","unstructured":"Amthor, H. et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 270, 19\u201330, https:\/\/doi.org\/10.1016\/j.ydbio.2004.01.046 (2004).","journal-title":"Dev Biol"},{"key":"23860_CR25","doi-asserted-by":"publisher","first-page":"e17911","DOI":"10.1371\/journal.pone.0017911","volume":"6","author":"M Ringner","year":"2011","unstructured":"Ringner, M., Fredlund, E., Hakkinen, J., Borg, A. & Staaf, J. GOBO: gene expression-based outcome for breast cancer online. PLoS One 6, e17911, https:\/\/doi.org\/10.1371\/journal.pone.0017911 (2011).","journal-title":"PLoS One"},{"key":"23860_CR26","doi-asserted-by":"publisher","first-page":"e1006706","DOI":"10.1371\/journal.pgen.1006706","volume":"13","author":"L Folkersen","year":"2017","unstructured":"Folkersen, L. et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet 13, e1006706, https:\/\/doi.org\/10.1371\/journal.pgen.1006706 (2017).","journal-title":"PLoS Genet"},{"key":"23860_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcdb.2014.01.005","volume":"28","author":"C Berasain","year":"2014","unstructured":"Berasain, C. & Avila, M. A. Amphiregulin. Semin Cell Dev Biol 28, 31\u201341, https:\/\/doi.org\/10.1016\/j.semcdb.2014.01.005 (2014).","journal-title":"Semin Cell Dev Biol"},{"key":"23860_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/onc.2015.93","volume":"35","author":"S Carvalho","year":"2016","unstructured":"Carvalho, S. et al. An antibody to amphiregulin, an abundant growth factor in patients\u2019 fluids, inhibits ovarian tumors. Oncogene 35, 438\u2013447, https:\/\/doi.org\/10.1038\/onc.2015.93 (2016).","journal-title":"Oncogene"},{"key":"23860_CR29","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"SJ Lee","year":"2001","unstructured":"Lee, S. J. & McPherron, A. C. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98, 9306\u20139311, https:\/\/doi.org\/10.1073\/pnas.151270098 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"23860_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000448247","volume":"99","author":"L Campins","year":"2017","unstructured":"Campins, L. et al. Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review. Pharmacology 99, 1\u20138, https:\/\/doi.org\/10.1159\/000448247 (2017).","journal-title":"Pharmacology"},{"key":"23860_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","volume":"359","author":"G Onder","year":"2002","unstructured":"Onder, G. et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 359, 926\u2013930 (2002).","journal-title":"Lancet"},{"key":"23860_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","volume":"3","author":"C Becker","year":"2015","unstructured":"Becker, C. et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3, 948\u2013957, https:\/\/doi.org\/10.1016\/S2213-8587(15)00298-3 (2015).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"23860_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","volume":"183","author":"JD Tune","year":"2017","unstructured":"Tune, J. D., Goodwill, A. G., Sassoon, D. J. & Mather, K. J. Cardiovascular consequences of metabolic syndrome. Transl Res 183, 57\u201370, https:\/\/doi.org\/10.1016\/j.trsl.2017.01.001 (2017).","journal-title":"Transl Res"},{"key":"23860_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fphys.2013.00265","volume":"4","author":"M Ciccarelli","year":"2013","unstructured":"Ciccarelli, M., Santulli, G., Pascale, V., Trimarco, B. & Iaccarino, G. Adrenergic receptors and metabolism: role in development of cardiovascular disease. Front Physiol 4, 265, https:\/\/doi.org\/10.3389\/fphys.2013.00265 (2013).","journal-title":"Front Physiol"},{"key":"23860_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11906-018-0801-2","volume":"20","author":"S Kachur","year":"2018","unstructured":"Kachur, S., Morera, R., De Schutter, A. & Lavie, C. J. Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome. Curr Hypertens Rep 20, 15, https:\/\/doi.org\/10.1007\/s11906-018-0801-2 (2018).","journal-title":"Curr Hypertens Rep"},{"key":"23860_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/hmg\/ddn350","volume":"18","author":"A Johansson","year":"2009","unstructured":"Johansson, A. et al. Common variants in the JAZF1 gene associated with height identified by linkage and genome-wide association analysis. Hum Mol Genet 18, 373\u2013380 (2009).","journal-title":"Hum Mol Genet"},{"key":"23860_CR37","first-page":"1363","volume":"10","author":"W Igl","year":"2010","unstructured":"Igl, W., Johansson, A. & Gyllensten, U. The Northern Swedish Population Health Study (NSPHS)\u2013a paradigmatic study in a rural population combining community health and basic research. Rural and remote health 10, 1363 (2010).","journal-title":"Rural and remote health"},{"key":"23860_CR38","doi-asserted-by":"publisher","unstructured":"Enroth, S., Dahlbom, I., Hansson, T., Johansson, A. & Gyllensten, U. Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health Study. International journal of circumpolar health 72, https:\/\/doi.org\/10.3402\/ijch.v72i0.21403 (2013).","DOI":"10.3402\/ijch.v72i0.21403"},{"key":"23860_CR39","doi-asserted-by":"publisher","unstructured":"Igl, W. et al. Animal source food intake and association with blood cholesterol, glycerophospholipids and sphingolipids in a northern Swedish population. International journal of circumpolar health 72, https:\/\/doi.org\/10.3402\/ijch.v72i0.21162 (2013).","DOI":"10.3402\/ijch.v72i0.21162"},{"key":"23860_CR40","doi-asserted-by":"publisher","unstructured":"Enroth, S., Hallmans, G., Grankvist, K. & Gyllensten, U. Effects of Long-Term Storage Time and Original Sampling Month on Biobank Plasma Protein Concentrations. EBioMedicine, 12, 309-314 https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.038.","DOI":"10.1016\/j.ebiom.2016.08.038"},{"key":"23860_CR41","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA: the journal of the American Medical Association 284, 3043\u20133045 (2000).","DOI":"10.1001\/jama.284.23.3043"},{"key":"23860_CR42","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability. PLoS ONE 9, e95192, https:\/\/doi.org\/10.1371\/journal.pone.0095192 (2014).","journal-title":"PLoS ONE"},{"key":"23860_CR43","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1073\/pnas.1217238110","volume":"110","author":"A Johansson","year":"2013","unstructured":"Johansson, A. et al. Identification of genetic variants influencing the human plasma proteome. Proc Natl Acad Sci USA 110, 4673\u20134678, https:\/\/doi.org\/10.1073\/pnas.1217238110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"23860_CR44","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.2354","volume":"44","author":"B Howie","year":"2012","unstructured":"Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nature genetics 44, 955\u2013959, https:\/\/doi.org\/10.1038\/ng.2354 (2012).","journal-title":"Nature genetics"},{"key":"23860_CR45","unstructured":"IMPUTE2 reference panels. https:\/\/mathgen.stats.ox.ac.uk\/impute\/1000GP_Phase3.html, http:\/\/mathgen.stats.ox.ac.uk\/impute\/impute_v2.html-reference (2015)."},{"key":"23860_CR46","unstructured":"Freeman, C. & Marchini, J. GTOOL, http:\/\/www.well.ox.ac.uk\/~cfreeman\/software\/gwas\/gtool.html (2015)."},{"key":"23860_CR47","unstructured":"Band, G. & Marchini, J. QCTOOL, http:\/\/www.well.ox.ac.uk\/~gav\/qctool\/, http:\/\/www.well.ox.ac.uk\/~gav\/qctool\/ (2015)."},{"key":"23860_CR48","unstructured":"R Develpment Core Team. R: A language and environment for statistical computing., (R Foundation for Statistical Computing, 2015)."},{"key":"23860_CR49","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1021\/acs.jproteome.5b01131","volume":"15","author":"MG Hong","year":"2016","unstructured":"Hong, M. G., Lee, W., Nilsson, P., Pawitan, Y. & Schwenk, J. M. Multidimensional Normalization to Minimize Plate Effects of Suspension Bead Array Data. J Proteome Res 15, 3473\u20133480, https:\/\/doi.org\/10.1021\/acs.jproteome.5b01131 (2016).","journal-title":"J Proteome Res"},{"key":"23860_CR50","unstructured":"Model Evaluation and Analysis. v. R-package version 1.2.8 build r99 (https:\/\/r-forge.r-project.org\/projects\/modeva\/, 2016)."},{"key":"23860_CR51","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/bioinformatics\/btm108","volume":"23","author":"YS Aulchenko","year":"2007","unstructured":"Aulchenko, Y. S., Ripke, S., Isaacs, A. & Van Duijn, C. M. GenABEL: an R library for genome-wide association analysis. Bioinformatics 23, 1294\u20131296, https:\/\/doi.org\/10.1093\/Bioinformatics\/Btm108 (2007).","journal-title":"Bioinformatics"},{"key":"23860_CR52","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38, e164, https:\/\/doi.org\/10.1093\/nar\/gkq603 (2010).","journal-title":"Nucleic Acids Res"},{"key":"23860_CR53","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842, https:\/\/doi.org\/10.1093\/bioinformatics\/btq033 (2010).","journal-title":"Bioinformatics"},{"key":"23860_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18637\/jss.v028.c01","volume":"28","author":"P Kampstra","year":"2008","unstructured":"Kampstra, P. Beanplot: A Boxplot Alternative for Visual Comparison of Distributions. Journal of Statistical Software 28, 9, https:\/\/doi.org\/10.18637\/jss.v028.c01 (2008).","journal-title":"Journal of Statistical Software"},{"key":"23860_CR55","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize Implements and enhances circular visualization in R. Bioinformatics 30, 2811\u20132812, https:\/\/doi.org\/10.1093\/bioinformatics\/btu393 (2014).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23860-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:04:20Z","timestamp":1671595460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23860-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23860"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23860-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The views presented are those of the authors and do not represent an official position of the Medical Products Agency to which one of the authors (SBE) is affiliated. SE has previously been a part-time employee of Olink Proteomics AB. Olink Proteomics AB had no role in funding of the study, the study design, collection of samples, analysis, interpretation of data, writing of the paper nor the decision to submit for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5531"}}